Schepens Eye Research institute/Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, MA, United States.
Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
Front Immunol. 2021 Apr 22;12:618653. doi: 10.3389/fimmu.2021.618653. eCollection 2021.
The amount of mucin secreted by conjunctival goblet cells is regulated to ensure the optimal level for protection of the ocular surface. Under physiological conditions lipid specialized pro-resolving mediators (SPM) are essential for maintaining tissue homeostasis including the conjunctiva. The protein Annexin A1 (AnxA1) can act as an SPM. We used cultured rat conjunctival goblet cells to determine if AnxA1 stimulates an increase in intracellular [Ca] ([Ca]) and mucin secretion and to identify the signaling pathways. The increase in [Ca] was determined using fura2/AM and mucin secretion was measured using an enzyme-linked lectin assay. AnxA1 stimulated an increase in [Ca] and mucin secretion that was blocked by the cell-permeant Ca chelator BAPTA/AM and the ALX/FPR2 receptor inhibitor BOC2. AnxA1 increased [Ca] to a similar extent as the SPMs lipoxin A and Resolvin (Rv) D1 and histamine. The AnxA1 increase in [Ca] and mucin secretion were inhibited by blocking the phospholipase C (PLC) pathway including PLC, the IP receptor, the Ca/ATPase that causes the intracellular Ca stores to empty, and blockade of Ca influx. Inhibition of protein kinase C (PKC) and Ca/calmodulin-dependent protein kinase also decreased the AnxA1-stimulated increase in [Ca] and mucin secretion. In contrast inhibitors of ERK 1/2, phospholipase A (PLA), and phospholipase D (PLD) did not alter AnxA1-stimulated increase in [Ca], but did inhibit mucin secretion. Activation of protein kinase A did not decrease either the AnxA1-stimulated rise in [Ca] or secretion. We conclude that in health, AnxA1 contributes to the mucin layer of the tear film and ocular surface homeostasis by activating the PLC signaling pathway to increase [Ca] and stimulate mucin secretion and ERK1/2, PLA, and PLD to stimulate mucin secretion from conjunctival goblet cells.
结膜杯状细胞分泌的粘蛋白量受到调节,以确保保护眼表面的最佳水平。在生理条件下,脂质特异性促解决介质(SPM)对于维持组织内稳态至关重要,包括结膜。蛋白 Annexin A1(AnxA1)可以作为 SPM。我们使用培养的大鼠结膜杯状细胞来确定 AnxA1 是否刺激细胞内 [Ca]([Ca])和粘蛋白分泌增加,并确定信号通路。使用 fura2/AM 测定 [Ca]的增加,并用酶联凝集素测定法测量粘蛋白分泌。AnxA1 刺激 [Ca]和粘蛋白分泌增加,该增加被细胞通透钙螯合剂 BAPTA/AM 和 ALX/FPR2 受体抑制剂 BOC2 阻断。AnxA1 增加 [Ca]的程度与 SPMs 脂氧素 A 和 Resolvin(Rv)D1 和组胺相似。阻断包括 PLC、IP 受体、导致细胞内钙储存排空的 Ca/ATP 酶和 Ca 流入在内的磷脂酶 C(PLC)途径,以及抑制蛋白激酶 C(PKC)和 Ca/钙调蛋白依赖性蛋白激酶,均可抑制 AnxA1 引起的 [Ca]增加和粘蛋白分泌。相反,ERK 1/2、磷脂酶 A(PLA)和磷脂酶 D(PLD)抑制剂不会改变 AnxA1 刺激的 [Ca]增加,但会抑制粘蛋白分泌。蛋白激酶 A 的激活既不会降低 AnxA1 刺激的 [Ca]上升,也不会降低分泌。我们的结论是,在健康状态下,AnxA1 通过激活 PLC 信号通路增加 [Ca]和刺激粘蛋白分泌,以及激活 ERK1/2、PLA 和 PLD 来刺激结膜杯状细胞的粘蛋白分泌,从而有助于泪膜和眼表面内稳态的粘蛋白层。